EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Anti‐Inflammatory Macrophage‐Derived Exosomes Modified With Self‐Antigen Peptides for Treatment of Experimental Autoimmune Encephalomyelitis

Qiaoyun Li, Jinwon Park, Jung Suk Kim, Quoc-Viet Le, Jaiwoo Lee, Yu-Kyoung Oh iD

Advanced Science · 2025-04 · 12 (13)

DOI: 10.1002/advs.202415265 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, online erschienen am 12.02.2025. Verfasst von Qiaoyun Li und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Exosomes, Macrophages, Autoantigens. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alchemist Project of the Korea Evaluation Institute of Industrial Technology (KEIT), Ministry of Trade, Industry and Energy, Republic of Korea, National Research Foundation (NRF), Ministry of Science and ICT, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current treatments for autoimmune diseases often involve broad‐acting immunosuppressants, which carry risks such as infections and malignancies. This study investigates whether exosomes derived from anti‐inflammatory macrophages (AE) and decorated with myelin oligodendrocyte glycoprotein (MOG) peptide (AE/M) can induce immune tolerance in autoimmune diseases. Experimental autoimmune encephalomyelitis (EAE), a mouse model for multiple sclerosis, serves as the autoimmune disease model. Exosomes derived from myoblasts or fibroblasts are also modified with MOG peptides for comparison. Unlike their myoblast or fibroblast counterparts, exosomes from anti‐inflammatory macrophages demonstrate a targeted capacity toward antigen‐presenting cells. Moreover, AE/M uniquely promotes the differentiation of dendritic cells (DC) into a tolerogenic phenotype. When splenocytes are treated with AE/M, an increased population of tolerogenic DC (tolDC) is observed, even under proinflammatory stimuli. Subcutaneous administration of AE/M in the EAE mouse model results in MOG peptide‐specific immune tolerance and preserves motor coordination. In contrast to treatments with fibroblast‐ or myoblast‐derived exosomes modified with MOG peptides, AE/M treatment provides complete protection from EAE in mice. These findings highlight the potential of self‐antigen modified AE as a versatile and adaptable nanoplatform for the treatment of various autoimmune diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalExosomesMacrophagesAutoantigensAnimalsMiceMyelin-Oligodendrocyte GlycoproteinMice, Inbred C57BLFemaleDisease Models, AnimalDendritic CellsImmune Tolerance

Stichwörter der Autor:innen

anti‐inflammatory macrophage‐derived exosomeautoimmune diseaseencephalomyelitisimmune toleranceself‐antigen modification

Substanzen

Myelin-Oligodendrocyte GlycoproteinAutoantigens

Autor:innen und Institutionen

  • College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, 08826, Republic of Korea.
  • Faculty of Pharmacy, Ton Duc Thang University, Ho Chi Minh City, 700000, Vietnam.
  • College of Pharmacy, Korea University, Sejong, 30019, Republic of Korea.

ORCID-Profile: Yu-Kyoung Oh

Förderung

  • Alchemist Project of the Korea Evaluation Institute of Industrial Technology (KEIT), Ministry of Trade, Industry and Energy, Republic of Korea
  • National Research Foundation (NRF), Ministry of Science and ICT, Republic of Korea

Zitieren

APA

Li, Q., Park, J., Kim, J. S., Le, Q. V., Lee, J., & Oh, Y. K. (2025). Anti‐Inflammatory Macrophage‐Derived Exosomes Modified With Self‐Antigen Peptides for Treatment of Experimental Autoimmune Encephalomyelitis. Advanced Science, 12(13). https://doi.org/10.1002/advs.202415265

Vancouver

Li Q, Park J, Kim JS, Le QV, Lee J, Oh YK. Anti‐Inflammatory Macrophage‐Derived Exosomes Modified With Self‐Antigen Peptides for Treatment of Experimental Autoimmune Encephalomyelitis. Advanced Science. 2025;12(13). doi:10.1002/advs.202415265

BibTeX
@article{Li2025,
  author = {Li, Qiaoyun and Park, Jinwon and Kim, Jung Suk and Le, Quoc-Viet and Lee, Jaiwoo and Oh, Yu-Kyoung},
  title = {Anti‐Inflammatory Macrophage‐Derived Exosomes Modified With Self‐Antigen Peptides for Treatment of Experimental Autoimmune Encephalomyelitis},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {13},
  doi = {10.1002/advs.202415265}
}
Kostenlos starten →